• Introducing ZedScan

    ZedScan™ is a diagnostic system used as an adjunct to standard colposcopy to provide an objective assessment of the cervical epithelial tissue in real time. ZedScan, Zilico’s first to market device, uses Electrical Impedance Spectroscopy (EIS) to differentiate between normal, pre-cancerous and cancerous tissue on the cervix according to its electrical properties. When used alongside colposcopy, ZedScan has demonstrated greater accuracy in detecting cervical disease.

Zilico commit to Time to Test with Jo's Cervical Cancer Trust

What is ZedScan?

Faster Diagnosis

Introducing the Next Generation of Diagnostics

Zilico is developing the next generation of diagnostic devices that remove subjectivity, increase accuracy and deliver results in real-time. These characteristics allow for the improvement and extension of clinical screening programmes globally.

Zilico's product portfolio is centred on its patented Electrical Impedance Spectroscopy (EIS) technology which has applicability across a wide range of neoplastic conditions. 

Electrical Impedance Spectroscopy as a Diagnostic Tool

  • EIS is an objective scientifically-proven method to differentiate between normal, pre cancerous and cancerous tissues (neoplasias)
  • EIS exploits the different electrical resistivity of each specific tissue type based on its cellular structure 
  • EIS is appropriate for the diagnosis of various cancers and pre-cancerous conditions
  • Zilico's lead product ZedScan  is utilised within the cervical cancer diagnostic pathway